Condition: Multiple SclerosisInterventions: Drug: Pioglitazone; Drug: clemastine fumarate; Drug: Dantrolene; Drug: PirfenidoneSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting Author:
Category: Conditions
General news and information about conditions and diseases
The Effect of an Interactive Web-based Program in the Management of Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Behavioral: YönetebilirimSponsor: Selcuk UniversityRecruiting Author:
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients – an Observational Study
Condition: Multiple SclerosisIntervention: Other: OfatumumabSponsor: Novartis PharmaceuticalsRecruiting Author:
PET Imaging of Cyclooxygenase-2 in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: 11C-MCI; Drug: 11C-PS13Sponsors: National Institute of Mental Health (NIMH); University of MarylandRecruiting Author:
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
Condition: Progressive Multiple SclerosisInterventions: Drug: Placebo; Drug: Masitinib (4.5)Sponsor: AB ScienceRecruiting Author:
Fatigue and Sleep Quality in Multiple Sclerosis Patients
Condition: Multiple SclerosisIntervention: Other: ReikiSponsor: Istanbul Sabahattin Zaim UniversityRecruiting Author:
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Drug: AnakinraSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Lower Extremities Closed Kinetic Chain Training for People With MS
Condition: Multiple SclerosisIntervention: Combination Product: Telko plus conventional physical therapy (CPT)Sponsor: Anas Radi Hassan AlashramRecruiting Author:
Tolebrutinib, a Brain-penetrant Bruton s Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: tolebrutinib 60mg; Drug: tolebrutinib 120mgSponsor: National Institute of Neurological Disorders and Stroke (NINDS)Recruiting Author:
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Condition: Relapsing Multiple SclerosisInterventions: Drug: Remibrutinib; Drug: TeriflunomideSponsor: Novartis PharmaceuticalsRecruiting Author:
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis
Condition: Multiple Sclerosis (MS)Interventions: Drug: Ocrelizumab; Drug: rHuPH20Sponsor: Hoffmann-La RocheActive, not recruiting Author:
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple SclerosisInterventions: Drug: Teriflunomide; Drug: PlaceboSponsor: Genzyme, a Sanofi CompanyActive, not recruiting Author: